Tech Company Financing Transactions
Smartlens Funding Round
Smartlens, operating out of Mountain View, secured $6.1 million in investment from Ambit Health Ventures, 3E Bioventures and Boutique Venture Partners.
Transaction Overview
Company Name
Announced On
7/11/2023
Transaction Type
Venture Equity
Amount
$6,100,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance regulatory clearance for miLens, a novel, electronics-free, soft contact lens for monitoring diurnal intraocular pressure (IOP).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2483 Old Middlefield Way C
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
Smartlens is a clinical-stage company with its portfolio of innovative technologies for diagnosing and treating glaucoma, a chronic eye disease that ranks as the leading cause of irreversible blindness. The Company's flagship product, miLens, is an innovative, non-invasive, contact lens-based device capable of monitoring intraocular pressure--the primary and only treatable risk factor for glaucoma. This addresses a significant unmet need that has persisted since the 1950s.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Savas Komban
Chief Medical Officer
Ahmet Yazici
Chief Scientific Officer
Sevda Agaoglu
Browse more venture capital transactions:
Prev: 7/11/2023: Equabli venture capital transaction
Next: 7/11/2023: RightRev venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs